IFNG and myeloid sarcoma: Additionally, 5-HT reduced IFNγ and IL-17 secretion by CD8+T cells, enhanced Treg function, and favored the expansion of FoxP3+CD39+ Treg and Treg17 cells, a novel Treg subset from MS patients (186).